News
U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...
Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...
President Donald Trump on Tuesday signed an executive order to lower prescription drug prices through a series of measures, ...
The Department of Commerce launched an investigation on April 1 into the national security impacts of importing drugs and ...
In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...
18h
TipRanks on MSNNovo Nordisk warns consumers about counterfeit Ozempic injectionsNovo Nordisk (NVO) has become aware of several hundred units of Ozempic injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the U.S., the company announced. The Food and ...
HealthDay News — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results